Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Collaborative Study Group Trial of sulodexide in type 2 diabetic microalbuminuria
2005-003158-91Phase 3Completed
- Sponsor
- Keryx Biopharmaceuticals
- Start
- Aug 2005
- Countries
- 1
01
Overview
Phase 3 trial of sulodexide in diabetic glomerulosclerosis and Microalbuminuria (2 arms), sponsored by Keryx Biopharmaceuticals. Primary endpoint: Therapeutic success at Week 26. Started Aug 2005; status: completed.
02
Drugs
sulodexide
03
Conditions
diabetic glomerulosclerosisMicroalbuminuria
Beyond the preview
Go deeper on 2005-003158-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003158-91.